You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Kronos is working with Tempus to sequence patients' tumor samples in the study for MYC amplification and overexpression.
The acquisition, 10x Genomics' fifth, could boost the firm's offerings for immune cell detection and discovery.
Oncocyte is now the sole shareholder of Razor, which developed the DetermaRx test that has now become the firm's flagship clinical offering.
For the 12 months ended Dec. 31, 2020, Biocartis' revenues rose to €43.1 million ($52.7 million) from €37.4 million in 2019.
The firm said its test eliminates the need for automated extraction systems in a high-volume PCR laboratory, reducing processing time, cost, and labor.
The firm will use the funds primarily to expand a beta program supporting a full commercial launch of its first platform, the Miro Canvas sample prep system.
The firm said its revenues for the three months ended Dec. 31, 2020 were $78.3 million compared to $62.9 million in the same quarter of 2019.
The immune cell sequencing company beat Wall Street estimates on the top line, but missed on the bottom line for both Q4 and full-year 2020.
The company reported $58.6 million in total revenues for the quarter and said testing services revenues rose 73 percent year over year.
The drugstore will sell Pixel by Labcorp kits in up to 6,000 stores, with the goal of providing a testing option at stores that don't currently have on-site testing.
The polygenic risk test analyzes an individual's genes for more than 100,000 SNPs associated with the risk of developing Alzheimer's disease.
Researchers identified new cell cycle proteins and their expression through single-cell transcriptome sequencing, proteomic, and other approaches.
The companies will use their respective technologies and expertise to identify multi-gene biomarkers that can be used in cancer drug discovery.
Investigators detected more than 100 risk loci for primary open-angle glaucoma, with mostly similar effects in people with European, Asian, or African ancestry.
The partners will develop a test to identify women most likely to benefit from VGX-3100, Inovio's immunotherapy to treat HPV-associated advanced cervical dysplasia.
The firm reported revenues of $126.0 million for the three-month period ended Dec. 31, 2020, up from $106.9 million in the same period last year.
The firm guided for 2021 revenue growth of between 5 percent and 8 percent, citing "a persistently uncertain business environment."
The Chinese company said it would use some of the funding to advance its integrated diagnostics research and development pipeline.
RenalytixAI will provide financial support to the University of Utah in the form of sponsored research into kidney disease progression, treatment, and biomarkers.
Total revenues for the period were $154.6 million, down from $195.1 million but beating the consensus Wall Street estimate.
Laboratory staffing and supply shortages limited patient access to cancer screening tests, and the pandemic decreased the development and validation of new tests.
G+FLAS said it provides CRISPR-related research services, tools, and reagents and applies CRISPR technology to develop drugs and produce genome-edited plants.
A pair of studies published this week present an analysis of a real, large-scale testing pooling effort as well as analyses of how to further improve such strategies.
The platform, based on the firm's Hi-C technology, is designed to assembly viral genomes from metagenomic samples and associate them with their microbial hosts.
The Paris-based company plans to use the nucleic acid modification technology to synthesize qPCR probes for use in diagnostics, among other biomolecules.
SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.
The New York Times reports that a new viral variant of concern has been identified in New York City.
In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.
According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.